PMC:7228307 / 61402-61605 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"1234","span":{"begin":195,"end":199},"obj":"Gene"},{"id":"1237","span":{"begin":159,"end":169},"obj":"Chemical"},{"id":"1238","span":{"begin":174,"end":185},"obj":"Chemical"},{"id":"1242","span":{"begin":55,"end":73},"obj":"Disease"},{"id":"1243","span":{"begin":107,"end":121},"obj":"Disease"}],"attributes":[{"id":"A1234","pred":"tao:has_database_id","subj":"1234","obj":"Gene:2064"},{"id":"A1237","pred":"tao:has_database_id","subj":"1237","obj":"MESH:C485206"},{"id":"A1238","pred":"tao:has_database_id","subj":"1238","obj":"MESH:D000068878"},{"id":"A1242","pred":"tao:has_database_id","subj":"1242","obj":"MESH:D003141"},{"id":"A1243","pred":"tao:has_database_id","subj":"1243","obj":"MESH:D000230"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Indeed, in a small but contemporary example outside of infectious disease, the FDA‐approved combination in adenocarcinoma therapy uses a cocktail of two mAbs, pertuzumab and trastuzumab, against Her2.123"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T119","span":{"begin":55,"end":73},"obj":"Disease"},{"id":"T120","span":{"begin":107,"end":121},"obj":"Disease"}],"attributes":[{"id":"A119","pred":"mondo_id","subj":"T119","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A120","pred":"mondo_id","subj":"T120","obj":"http://purl.obolibrary.org/obo/MONDO_0004970"}],"text":"Indeed, in a small but contemporary example outside of infectious disease, the FDA‐approved combination in adenocarcinoma therapy uses a cocktail of two mAbs, pertuzumab and trastuzumab, against Her2.123"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T996","span":{"begin":11,"end":12},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T997","span":{"begin":135,"end":136},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"Indeed, in a small but contemporary example outside of infectious disease, the FDA‐approved combination in adenocarcinoma therapy uses a cocktail of two mAbs, pertuzumab and trastuzumab, against Her2.123"}

{"project":"LitCovid-sample-PD-IDO","denotations":[{"id":"T264","span":{"begin":55,"end":73},"obj":"http://purl.obolibrary.org/obo/IDO_0000436"},{"id":"T265","span":{"begin":66,"end":73},"obj":"http://purl.obolibrary.org/obo/OGMS_0000031"}],"text":"Indeed, in a small but contemporary example outside of infectious disease, the FDA‐approved combination in adenocarcinoma therapy uses a cocktail of two mAbs, pertuzumab and trastuzumab, against Her2.123"}

{"project":"LitCovid-sample-Enju","denotations":[{"id":"T612","span":{"begin":0,"end":6},"obj":"RB"},{"id":"T613","span":{"begin":6,"end":7},"obj":"-COMMA-"},{"id":"T614","span":{"begin":8,"end":10},"obj":"IN"},{"id":"T615","span":{"begin":11,"end":12},"obj":"DT"},{"id":"T616","span":{"begin":13,"end":18},"obj":"JJ"},{"id":"T617","span":{"begin":19,"end":22},"obj":"CC"},{"id":"T618","span":{"begin":23,"end":35},"obj":"JJ"},{"id":"T619","span":{"begin":36,"end":43},"obj":"NN"},{"id":"T620","span":{"begin":44,"end":51},"obj":"IN"},{"id":"T621","span":{"begin":52,"end":54},"obj":"IN"},{"id":"T622","span":{"begin":55,"end":65},"obj":"JJ"},{"id":"T623","span":{"begin":66,"end":73},"obj":"NN"},{"id":"T624","span":{"begin":73,"end":74},"obj":"-COMMA-"},{"id":"T625","span":{"begin":75,"end":78},"obj":"DT"},{"id":"T626","span":{"begin":79,"end":91},"obj":"NNP"},{"id":"T627","span":{"begin":92,"end":103},"obj":"NN"},{"id":"T628","span":{"begin":104,"end":106},"obj":"IN"},{"id":"T629","span":{"begin":107,"end":121},"obj":"NN"},{"id":"T630","span":{"begin":122,"end":129},"obj":"NN"},{"id":"T631","span":{"begin":130,"end":134},"obj":"VBZ"},{"id":"T632","span":{"begin":135,"end":136},"obj":"DT"},{"id":"T633","span":{"begin":137,"end":145},"obj":"NN"},{"id":"T634","span":{"begin":146,"end":148},"obj":"IN"},{"id":"T635","span":{"begin":149,"end":152},"obj":"CD"},{"id":"T636","span":{"begin":153,"end":157},"obj":"NNS"},{"id":"T637","span":{"begin":157,"end":158},"obj":"-COMMA-"},{"id":"T638","span":{"begin":159,"end":169},"obj":"NN"},{"id":"T639","span":{"begin":170,"end":173},"obj":"CC"},{"id":"T640","span":{"begin":174,"end":185},"obj":"NN"},{"id":"T641","span":{"begin":185,"end":186},"obj":"-COMMA-"},{"id":"T642","span":{"begin":187,"end":194},"obj":"IN"},{"id":"T643","span":{"begin":195,"end":203},"obj":"NN"}],"relations":[{"id":"R628","pred":"arg1Of","subj":"T631","obj":"T612"},{"id":"R629","pred":"arg1Of","subj":"T631","obj":"T613"},{"id":"R630","pred":"arg1Of","subj":"T631","obj":"T614"},{"id":"R631","pred":"arg2Of","subj":"T619","obj":"T614"},{"id":"R632","pred":"arg1Of","subj":"T619","obj":"T615"},{"id":"R633","pred":"arg1Of","subj":"T619","obj":"T616"},{"id":"R634","pred":"arg1Of","subj":"T616","obj":"T617"},{"id":"R635","pred":"arg2Of","subj":"T618","obj":"T617"},{"id":"R636","pred":"arg1Of","subj":"T619","obj":"T618"},{"id":"R637","pred":"arg1Of","subj":"T619","obj":"T620"},{"id":"R638","pred":"arg1Of","subj":"T620","obj":"T621"},{"id":"R639","pred":"arg2Of","subj":"T623","obj":"T621"},{"id":"R640","pred":"arg1Of","subj":"T623","obj":"T622"},{"id":"R641","pred":"arg1Of","subj":"T631","obj":"T624"},{"id":"R642","pred":"arg1Of","subj":"T627","obj":"T625"},{"id":"R643","pred":"arg1Of","subj":"T627","obj":"T626"},{"id":"R644","pred":"arg1Of","subj":"T627","obj":"T628"},{"id":"R645","pred":"arg2Of","subj":"T630","obj":"T628"},{"id":"R646","pred":"arg1Of","subj":"T630","obj":"T629"},{"id":"R647","pred":"arg1Of","subj":"T627","obj":"T631"},{"id":"R648","pred":"arg2Of","subj":"T633","obj":"T631"},{"id":"R649","pred":"arg1Of","subj":"T633","obj":"T632"},{"id":"R650","pred":"arg1Of","subj":"T633","obj":"T634"},{"id":"R651","pred":"arg2Of","subj":"T636","obj":"T634"},{"id":"R652","pred":"arg1Of","subj":"T636","obj":"T635"},{"id":"R653","pred":"arg1Of","subj":"T633","obj":"T637"},{"id":"R654","pred":"arg2Of","subj":"T639","obj":"T637"},{"id":"R655","pred":"arg1Of","subj":"T638","obj":"T639"},{"id":"R656","pred":"arg2Of","subj":"T640","obj":"T639"},{"id":"R657","pred":"arg1Of","subj":"T631","obj":"T641"},{"id":"R658","pred":"arg1Of","subj":"T631","obj":"T642"},{"id":"R659","pred":"arg2Of","subj":"T643","obj":"T642"}],"text":"Indeed, in a small but contemporary example outside of infectious disease, the FDA‐approved combination in adenocarcinoma therapy uses a cocktail of two mAbs, pertuzumab and trastuzumab, against Her2.123"}

{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"1234","span":{"begin":195,"end":199},"obj":"Gene"},{"id":"1237","span":{"begin":159,"end":169},"obj":"Chemical"},{"id":"1238","span":{"begin":174,"end":185},"obj":"Chemical"},{"id":"1242","span":{"begin":55,"end":73},"obj":"Disease"},{"id":"1243","span":{"begin":107,"end":121},"obj":"Disease"}],"attributes":[{"id":"A1234","pred":"pubann:denotes","subj":"1234","obj":"Gene:2064"},{"id":"A1237","pred":"pubann:denotes","subj":"1237","obj":"MESH:C485206"},{"id":"A1238","pred":"pubann:denotes","subj":"1238","obj":"MESH:D000068878"},{"id":"A1242","pred":"pubann:denotes","subj":"1242","obj":"MESH:D003141"},{"id":"A1243","pred":"pubann:denotes","subj":"1243","obj":"MESH:D000230"}],"text":"Indeed, in a small but contemporary example outside of infectious disease, the FDA‐approved combination in adenocarcinoma therapy uses a cocktail of two mAbs, pertuzumab and trastuzumab, against Her2.123"}

{"project":"LitCovid-sample-sentences","denotations":[{"id":"T339","span":{"begin":0,"end":203},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Indeed, in a small but contemporary example outside of infectious disease, the FDA‐approved combination in adenocarcinoma therapy uses a cocktail of two mAbs, pertuzumab and trastuzumab, against Her2.123"}

{"project":"LitCovid-sample-PD-MONDO","denotations":[{"id":"T55","span":{"begin":55,"end":73},"obj":"Disease"},{"id":"T56","span":{"begin":107,"end":121},"obj":"Disease"}],"attributes":[{"id":"A55","pred":"mondo_id","subj":"T55","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A56","pred":"mondo_id","subj":"T56","obj":"http://purl.obolibrary.org/obo/MONDO_0004970"}],"text":"Indeed, in a small but contemporary example outside of infectious disease, the FDA‐approved combination in adenocarcinoma therapy uses a cocktail of two mAbs, pertuzumab and trastuzumab, against Her2.123"}

{"project":"LitCovid-sentences","denotations":[{"id":"T339","span":{"begin":0,"end":203},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Indeed, in a small but contemporary example outside of infectious disease, the FDA‐approved combination in adenocarcinoma therapy uses a cocktail of two mAbs, pertuzumab and trastuzumab, against Her2.123"}